结核病治疗期间头孢曲松诱发血小板减少症：病例报告。

IF 1.6 4区医学 Q3 PHARMACOLOGY & PHARMACY

European journal of hospital pharmacy : science and practice Pub Date : 2024-09-27 DOI:10.1136/ejhpharm-2024-004165

Matthijs Plas, Linda M Kampschreur, Johannes A Kroes, Leendert Porcelijn, Carina Bethlehem

{"title":"结核病治疗期间头孢曲松诱发血小板减少症：病例报告。","authors":"Matthijs Plas, Linda M Kampschreur, Johannes A Kroes, Leendert Porcelijn, Carina Bethlehem","doi":"10.1136/ejhpharm-2024-004165","DOIUrl":null,"url":null,"abstract":"We present a case of drug-induced immune thrombocytopenia (DITP) proven to be due to ceftriaxone instead of assumed tuberculostatic treatment in a patient with miliary tuberculosis. It is important to identify the culprit drug in DITP to avoid discontinuing essential treatment, especially when more than one drug is implicated. In these cases additional analysis (drug-dependent platelet antibody testing) should be considered to prevent unnecessary replacement of a first-line regimen of tuberculostatic treatment with an alternative treatment regime.","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report.\",\"authors\":\"Matthijs Plas, Linda M Kampschreur, Johannes A Kroes, Leendert Porcelijn, Carina Bethlehem\",\"doi\":\"10.1136/ejhpharm-2024-004165\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We present a case of drug-induced immune thrombocytopenia (DITP) proven to be due to ceftriaxone instead of assumed tuberculostatic treatment in a patient with miliary tuberculosis. It is important to identify the culprit drug in DITP to avoid discontinuing essential treatment, especially when more than one drug is implicated. In these cases additional analysis (drug-dependent platelet antibody testing) should be considered to prevent unnecessary replacement of a first-line regimen of tuberculostatic treatment with an alternative treatment regime.\",\"PeriodicalId\":12050,\"journal\":{\"name\":\"European journal of hospital pharmacy : science and practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of hospital pharmacy : science and practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2024-004165\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of hospital pharmacy : science and practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-004165","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

摘要

我们介绍了一例药物诱导的免疫性血小板减少症（DITP）病例，该病例被证实是由于头孢曲松而非假定的抗结核治疗所致。确定 DITP 的罪魁祸首药物非常重要，以避免中断必要的治疗，尤其是当牵涉到不止一种药物时。在这种情况下，应考虑进行额外的分析（药物依赖性血小板抗体检测），以防止不必要地用替代治疗方案取代一线抗结核治疗方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report.

We present a case of drug-induced immune thrombocytopenia (DITP) proven to be due to ceftriaxone instead of assumed tuberculostatic treatment in a patient with miliary tuberculosis. It is important to identify the culprit drug in DITP to avoid discontinuing essential treatment, especially when more than one drug is implicated. In these cases additional analysis (drug-dependent platelet antibody testing) should be considered to prevent unnecessary replacement of a first-line regimen of tuberculostatic treatment with an alternative treatment regime.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European journal of hospital pharmacy : science and practice PHARMACOLOGY & PHARMACY-

CiteScore

3.40

自引率

5.90%

发文量

104

审稿时长

6-12 weeks

期刊介绍： European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.